Saturday, August 14, 2021

Bharat Biotech's nasal Covid-19 vaccine advances into next stage of trials

Early stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be well tolerated

from Today's Paper https://ift.tt/3sh7FNm
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...